TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

Baxter

Infectious DiseaseCardiovascularOncology
Specialty

Baxter is a specialty pharmaceutical company focused on Infectious Disease, Cardiovascular, Oncology. Key products include CYCLOPHOSPHAMIDE.

1951
Since
304
Drugs
-
Trials
497
Approved (2yr)

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 24%
12 drugs
Cardiovascular 22%
11 drugs
Oncology 19%
9 drugs Phase 1: 1
Dermatology 18%
9 drugs
Ophthalmology 16%
8 drugs

Pipeline Strength Pro

Loading...